Synopsys (NASDAQ:SNPS – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 14.880-14.960 for the period, compared to the consensus EPS estimate of 14.890. The company issued revenue guidance of $6.7 billion-$6.8 billion, compared to the consensus revenue estimate of $6.8 billion. Synopsys also updated its Q2 2025 guidance to 3.370-3.420 EPS.
Analysts Set New Price Targets
A number of research analysts have weighed in on SNPS shares. Piper Sandler dropped their price objective on shares of Synopsys from $670.00 to $655.00 and set an “overweight” rating on the stock in a research note on Friday, December 6th. Morgan Stanley dropped their price target on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating on the stock in a research report on Monday. Needham & Company LLC reiterated a “buy” rating and set a $640.00 price target on shares of Synopsys in a research note on Thursday, December 5th. Wells Fargo & Company lowered their price objective on Synopsys from $570.00 to $540.00 and set an “equal weight” rating for the company in a research note on Monday, January 13th. Finally, Rosenblatt Securities reaffirmed a “buy” rating and set a $660.00 target price on shares of Synopsys in a research report on Tuesday. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $639.58.
Get Our Latest Stock Report on Synopsys
Synopsys Stock Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The semiconductor company reported $2.25 earnings per share for the quarter, missing the consensus estimate of $2.81 by ($0.56). Synopsys had a net margin of 36.12% and a return on equity of 20.48%. Equities research analysts forecast that Synopsys will post 10.64 earnings per share for the current fiscal year.
Insider Activity at Synopsys
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the transaction, the executive now owns 1,460 shares in the company, valued at $738,774.60. This trade represents a 93.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.66% of the stock is owned by company insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Buffett’s on the Sidelines – Should You Follow?
- Insider Trades May Not Tell You What You Think
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.